Financial Gravity Companies’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Financial Gravity Companies’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$5K	Buy	+100	New	+$3.75K	﹤0.01%	733

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Financial Gravity Companies's GBT Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Global Blood Therapeutics, Inc. (GBT) in Q4 2018: 100 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #733 among its holdings.

190 funds tracked by Wall St. Rank hold GBT as of Q4 2018.

Financial Gravity Companies held 100 shares of Global Blood Therapeutics, Inc. worth $5K as of Q4 2018.
Global Blood Therapeutics, Inc. was a new Financial Gravity Companies position in Q4 2018.
Global Blood Therapeutics, Inc. made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #733 holding.
190 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.